Literature DB >> 23721345

Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.

Yi Zhou1, Liu Hong.   

Abstract

BACKGROUND AND AIMS: Here, we have investigated the role of miR-483 and miR-214 in the prognosis and multidrug resistance (MDR) of esophageal squamous cell carcinoma.
METHODS: The expression of miR-483 and miR-214 was detected in 104 cases of esophageal cancer tissues and matched adjacent benign esophageal tissues by quantitative real-time PCR. The relation of microRNA expression with survival was statistically analyzed. The roles of miR-483 and miR-214 in MDR of esophageal squamous cell cancer cells were further evaluated.
RESULTS: The expression of miR-483 and miR-214 was found significantly upregulated in esophageal squamous cell cancer tissues. The expression levels of miR-483 and miR-214 showed an inverse correlation with overall survival. High expression of miR-483 and miR-214 might predict less chemotherapy effect. Downregulation of miR-483 and miR-214 could confer sensitivity of both P-glycoprotein-related and P-glycoprotein-nonrelated drugs to esophageal cancer cells, and it might induce increased accumulation of adriamycin (ADR) and decreased amount of ADR released.
CONCLUSIONS: miR-483 and miR-214 might play important roles in the pathogenesis of esophageal cancer and should be considered as potential targets for intervention in this malignancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23721345      PMCID: PMC3668496          DOI: 10.1089/gtmb.2012.0518

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  18 in total

1.  MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release.

Authors:  Alain van Mil; Sebastian Grundmann; Marie-José Goumans; Zhiyong Lei; Martinus I Oerlemans; Sridevi Jaksani; Pieter A Doevendans; Joost P G Sluijter
Journal:  Cardiovasc Res       Date:  2012-01-06       Impact factor: 10.787

Review 2.  Emerging role of microRNAs in drug-resistant breast cancer.

Authors:  Sarmila Majumder; Samson T Jacob
Journal:  Gene Expr       Date:  2011

Review 3.  The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas.

Authors:  Liu Hong; Yu Han; Shujun Li; Jianjun Yang; Jianyong Zheng; Hongwei Zhang; Qingchuan Zhao; Kaichun Wu; Daiming Fan
Journal:  Expert Opin Biol Ther       Date:  2010-10-26       Impact factor: 4.388

4.  MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).

Authors:  Soken Tsuchiya; Takeshi Fujiwara; Fumiaki Sato; Yutaka Shimada; Eiji Tanaka; Yoshiharu Sakai; Kazuharu Shimizu; Gozoh Tsujimoto
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

Review 5.  Angiogenesis-related molecular targets in esophageal cancer.

Authors:  Liu Hong; Shujun Li; Yu Han; Jianjun Du; Hongwei Zhang; Jipeng Li; Qingchuan Zhao; Kaichun Wu; Daiming Fan
Journal:  Expert Opin Investig Drugs       Date:  2011-03-28       Impact factor: 6.206

Review 6.  MicroRNAs in mutagenesis, genomic instability, and DNA repair.

Authors:  Dan-Avi Landau; Frank J Slack
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

7.  MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.

Authors:  Jun Hao; Shuyu Zhang; Yingqi Zhou; Xiangui Hu; Chenghao Shao
Journal:  FEBS Lett       Date:  2010-11-27       Impact factor: 4.124

Review 8.  MicroRNA involvement in esophageal carcinogenesis.

Authors:  Stefan David; Stephen J Meltzer
Journal:  Curr Opin Pharmacol       Date:  2011-10-10       Impact factor: 5.547

9.  MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.

Authors:  Erin E Patterson; Alisha K Holloway; Julie Weng; Tito Fojo; Electron Kebebew
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

10.  Dysregulation of miR-15a and miR-214 in human pancreatic cancer.

Authors:  Xing J Zhang; Hua Ye; Cheng W Zeng; Bo He; Hua Zhang; Yue Q Chen
Journal:  J Hematol Oncol       Date:  2010-11-24       Impact factor: 17.388

View more
  18 in total

1.  miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.

Authors:  Qijue Lu; Li Xu; Chunguang Li; Yang Yuan; Shengdong Huang; Hezhong Chen
Journal:  Tumour Biol       Date:  2016-09-12

Review 2.  The p53/microRNA connection in gastrointestinal cancer.

Authors:  Matjaz Rokavec; Huihui Li; Longchang Jiang; Heiko Hermeking
Journal:  Clin Exp Gastroenterol       Date:  2014-09-30

3.  Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression.

Authors:  Jinrong Liao; Jinghui Lin; Dong Lin; Changyan Zou; Jessica Kurata; Renjang Lin; Zhiyong He; Ying Su
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

4.  Blood-based circulating microRNAs as potential biomarkers for predicting the prognosis of head and neck cancer-a systematic review.

Authors:  Shankargouda Patil; Saman Warnakulasuriya
Journal:  Clin Oral Investig       Date:  2020-10-03       Impact factor: 3.573

5.  High-Throughput miRNA Sequencing Reveals a Field Effect in Gastric Cancer and Suggests an Epigenetic Network Mechanism.

Authors:  Monica B Assumpção; Fabiano C Moreira; Igor G Hamoy; Leandro Magalhães; Amanda Vidal; Adenilson Pereira; Rommel Burbano; André Khayat; Artur Silva; Sidney Santos; Samia Demachki; Ândrea Ribeiro-Dos-Santos; Paulo Assumpção
Journal:  Bioinform Biol Insights       Date:  2015-07-06

Review 6.  Role of miR-483 in digestive tract cancers: from basic research to clinical value.

Authors:  Wei Zhou; Wanli Yang; Jiaojiao Ma; Hongwei Zhang; Zeng Li; Lei Zhang; Jinqiang Liu; Zhenyu Han; Hu Wang; Liu Hong
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

7.  Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Tsutomu Kawaguchi; Hiroki Takeshita; Mahito Miyamae; Takuma Ohashi; Wataru Okajima; Taisuke Imamura; Jun Kiuchi; Tomohiro Arita; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Eigo Otsuji
Journal:  Oncotarget       Date:  2016-09-20

Review 8.  ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.

Authors:  David Vrana; Viktor Hlavac; Veronika Brynychova; Radka Vaclavikova; Cestmir Neoral; Jiri Vrba; Rene Aujesky; Marcel Matzenauer; Bohuslav Melichar; Pavel Soucek
Journal:  Int J Mol Sci       Date:  2018-03-15       Impact factor: 5.923

9.  A 10‑microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.

Authors:  Qingchao Sun; Liang Zong; Haiping Zhang; Yanchao Deng; Changming Zhang; Liwei Zhang
Journal:  Mol Med Rep       Date:  2018-02-02       Impact factor: 2.952

10.  MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.

Authors:  Julia Slotta-Huspenina; Enken Drecoll; Marcus Feith; Daniel Habermehl; Stephanie Combs; Wilko Weichert; Marcus Bettstetter; Karen Becker; Rupert Langer
Journal:  J Transl Med       Date:  2018-04-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.